Personalis, Inc. PSNL Inventory And Other Deferred Costs
Inventory And Other Deferred Costs at other companies
Other financials
Where this comes from
Reported directly by Personalis, Inc. in its filing.
Tagged under the XBRL concept psnl:InventoryAndOtherDeferredCosts.
The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Personalis, Inc.'s inventory and other deferred costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Personalis, Inc.'s inventory and other deferred costs?
- Personalis, Inc. (PSNL) reported inventory and other deferred costs of $6.93M in Q1 2026.
- How has Personalis, Inc.'s inventory and other deferred costs changed year-over-year?
- Personalis, Inc.'s inventory and other deferred costs increased by 40.8% year-over-year, from $4.92M to $6.93M.
- What is the long-term trend for Personalis, Inc.'s inventory and other deferred costs?
- Over 5 years (2020 to 2025), Personalis, Inc.'s inventory and other deferred costs has grown at a 1.7% compound annual growth rate (CAGR), from $5.64M to $6.14M.
- What does inventory and other deferred costs mean?
- This metric represents the aggregate value of raw materials, work-in-progress, and finished goods held for sequencing services, alongside deferred costs associated with fulfilling customer contracts. It reflects the capital tied up in operational inputs and the costs incurred to generate future revenue from genomic testing services. Monitoring this balance helps assess the efficiency of inventory management and the timing of revenue recognition relative to service delivery.